Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India Press Release Kashiv BioSciences and Intas Pharmaceuticals Sign an Exclusive Licensing and Supply Agreement for Complex Peptide Product in Europe, the UK & India The National Reader February 10, 2026 PISCATAWAY, N.J., [February 10, 2026]: Kashiv BioSciences, LLC (“Kashiv”) a vertically integrated biopharmaceutical company, today announced that...Read More
